CSW signs OEM agreement with Visbion

CSW Group LtdCSW Group has signed an OEM agreement with Visbion Ltd, whereby Visbion's DICOM imaging technology will be incorporated into CSW's Case Notes product for Electronic Health Records and sold as its new Diagnostic Image Management and Diagnostic Image Viewer modules.

Visbion specialises in medical image management and display solutions that support the acquisition, storage, archive and display of a wide range of medical images. This functionality will now be available through new Case Notes modules, which extend its capability to handle any diagnostic images - including X-Ray, CT and MRI - using the international DICOM 3.0 standard.

CSW holds a small shareholding in Visbion Ltd, a UK company that owns digital imaging technology originally developed over a fourteen year period at Imperial College, London. Visbion's technology integrates images from a wide range of clinical disciplines and provides specialist tools for radiologists, ophthalmologist and other healthcare professionals.

John Chelsom, Managing Director at CSW, commented, "The incorporation of Visbion's DICOM technology into Case Notes, is a further step towards its development as a cross agency care records system with full clinical functionality. Using Visbion's technology, Case Notes is now fully DICOM enabled, allowing it to handle a full range of diagnostic images within its single patient centred record."

Stefan Claesen, Chief Executive, Visbion Ltd added, "The Visbion technology gives the clinician access to all imaging from the single patient-centric record within CSW Case Notes. It delivers a truly distributed diagnostic image review capability and shares a proven, highly-scalable webbased platform with the Case Notes products. It is the perfect complement for the existing clinical functionality for order communications, results reporting and clinical noting in Case Notes."

Further information on the Case Notes product can be found at www.casenotes.co.uk

Related news articles:

About CSW Group Ltd
CSW Group Ltd is a leading provider of standards-based e-records products for healthcare and knowledge management in the UK. Using our unique combination of innovative technical skills, quality software engineering practices and in-depth knowledge of health, social care and pharmaceutical domains, CSW has developed its Case Notes™ and KMS™ products to address secure patient journey management, integrated clinical processes and knowledge management and delivery across the caring professions. CSW was founded in 1993 and is headquartered in Oxford, England. News and information are available at www.csw.co.uk.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...